Page 15 - Contracts And Orders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Contracts and orders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Contracts And Orders Today - Breaking & Trending Today

Asia Green Biotechnology Corp. Enters Memorandum of Agreement with Agricultural College in Cambodia to Evaluate Hemp Production Potential

Press release content from Accesswire. The AP news staff was not involved in its creation.
Asia Green Biotechnology Corp. Enters Memorandum of Agreement with Agricultural College in Cambodia to Evaluate Hemp Production Potential
March 8, 2021 GMT
CALGARY, AB / ACCESSWIRE / March 8, 2021 / Asia Green Biotechnology Corp. (“AGB” or the “Company”) (CSE:ASIA) announced today that the Company continues to successfully implement its business plan in SE Asia with the execution of a Memorandum of Understanding with the Prek Leap National Institute of Agriculture in Phnom Penh (“Prek Leap”). The purpose of this agreement is to allow AGB and Prek Leap to collaborate in the pursuit and execution of a business development plan tied to the evaluation and implementation of seed and plant production techniques relating to hemp and other plants with medicinal, practical or other benefits. Prek Leap will play a leading role in the research and development of industrial and o ....

Prek Leap , Phnom Penh , David Pinkman , Phnom Penh Prek , Igor Kovalchuk , Swysh Inc , Asia Cannabis Industry Co Ltd , Prek Leap National Institute Of Agriculture , Asia Green Biotechnology Corp , Inplanta Biotechnology Inc , Pathway Rx Inc , Regulation Services Provider , Asia Green Biotechnology , Prek Leap National Institute , Products And Services , Agricultural Sciences , Coronavirus Pandemic , Licensing Agreements , Lung Disease , Covid 19 Pandemic , Infectious Diseases , New Product Development , Contracts And Orders , Corporate News , Diseases And Conditions , New Products And Services ,

IMC to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC

Press release content from Accesswire. The AP news staff was not involved in its creation.
IMC to Bring Canadian Premium Indoor High-THC Medical Cannabis to Israel with Imports from GTEC
March 8, 2021 GMT
Multi-year agreement enables IMC to launch a premium product category in Israel - one of the world’s largest import markets for medical cannabis
The agreement adds another international partnership to IMC’s supply network
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 8, 2021 / IM Cannabis Corp. (the “Company” or “IMC”) (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (“MCO”) in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that Focus Medical Herbs Ltd. (“Focus Medical”), with which IMC has exclusive agreements to distribute production under the IMC brand, has signed a multi-year supply agreement with GTEC Holdings Ltd. (“GTEC”) (GTEC, GGTTF, 1BUP), a Canadian licensed producer of ha ....

United States , United Kingdom , British Columbia , Michael Blady , Gal Wilder , Oren Shuster , Adjupharm Gmbh , Im Cannabis Corp , Herbs Ltd , Head Of International Division , Holdings Ltd , Frankfurt Stock Exchange , Trichome Financial Inc , Grey Bruce Farms Incorporated , Health Canada , Israeli Ministry Of Health , Venture Exchange , Focus Medical Herbs , Focus Medical , Chief Executive Officer , Vice President , International Division , Israeli Ministry , Exclusive Term , North American , Greentec Medical ,

North Macedonia gets first batch of Russia vaccine Sputnik V

SKOPJE, North Macedonia (AP) — North Macedonia on Sunday received the first batch of 3,000 doses of Russian vaccine Sputnik V from a total order of 200,000 in the fight ....

Macedonia General , Venko Filipce , North Macedonia , Health Minister Venko Filipce , Chinese Sinopharm , Virus Outbreak North Macedonia Vaccines , General News , Government And Politics , Public Health , Covid 19 Pandemic , Corona Virus , Infectious Diseases , Diseases And Conditions , Lung Disease , Disease Outbreaks , Contracts And Orders , Corporate News , Covid 19 Vaccine Rollout , மாசிடோனியா ஜநரல் , வடக்கு மாசிடோனியா , வைரஸ் ஔட்‌ப்ரேக் வடக்கு மாசிடோனியா தடுப்பு மருந்துகள் , ஜநரல் செய்தி , அரசு மற்றும் பாலிடிக்ஸ் , பொது ஆரோக்கியம் , கொரோனா வைரஸ் , தொற்று நோய்கள் ,

Norsk Hydro: Hydro agrees to sell Rolling business area to KPS Capital Partners for EUR 1,380 ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Norsk Hydro: Hydro agrees to sell Rolling business area to KPS Capital Partners for EUR 1,380 .
Norsk HydroMarch 5, 2021 GMT
Energy and aluminium company Norsk Hydro ASA has entered into an agreement to sell its Rolling business to KPS Capital Partners for EUR 1,380 million on an enterprise value basis. A major step on Hydro’s agenda to improve profitability and drive sustainability.
The transaction includes seven plants, one R&D center, global sales offices, and around 5,000 employees of which 650 employees in Norway and the remaining mainly in Germany. ....

Einar Glomnes , Hilde Merete Aasheim , Halvor Molland , Michael Psaros , Norsk Hydro , Hydro President , Hydro Rolling , Framework Agreements , Co Managing Partner , Vice President , Hydro Investor Relations , Norwegian Securities Trading Act , Corporate News , Ownership Changes , Materials Industry , Asset Sales , Base Metals Industry , Globe Newswire , Contracts And Orders , Metals And Minerals Industry , Aluminum Mining And Refining , ஹால்வர் மாயாஂட் , நார்ஸ்க் ஹைட்ரோ , ஹைட்ரோ ப்ரெஸிடெஂட் , ஹைட்ரோ உருட்டுதல் , இணை நிர்வகித்தல் கூட்டாளர் ,

Hyloris' Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV .
Hyloris PharmaceuticalsMarch 5, 2021 GMT
Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets
Footprint across Europe now extended to a total of 20 EU member states
Maxigesic® IV offers a non-opioid alternative in post-operative pain management
Liège, Belgium – 5 March 2021 – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to bringing innovative treatments that offer added value to underserved patient populations, today announces that its partner AFT Pharmaceuticals (“AFT”) has signed an exclusive licensing agreement with Aguettant for Maxigesic IV, a novel, dual mode-of-action non-opioid pain treatment delivered through intravenous (IV) in ....

United Kingdom , Chris Welsh , Amber Fennell , Marieke Vermeersch , Stijn Van Rompay , Lucy Featherstone , Delveinsight Market Research , Hyloris Pharmaceuticals Sa Euronext Brussels , Pharmaceuticals Signs Licensing Agreement , Corporate Communications , Hyloris Pharmaceuticals , Consilium Strategic Communications , Hylori Partner , Signs Licensing Agreement , Height European , Euronext Brussels , Van Rompay , Chief Executive Officer , Insight Market Research Report , Licensing Agreements , Corporate News , Health Care Industry , Health Care Facility Operation , Hospital And Clinic Services , Diagnosis And Treatment , Globe Newswire ,